T. Rowe Price Associates »

Sutro Biopharma shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $62k 14k 4.29
2023-09-30 $46k 13k 3.51
2023-06-30 $54k 12k 4.68
2021-03-31 $487k 21k 22.76
2020-12-31 $455k 21k 21.70

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Sutro Biopharma

BVF
Vanguard Group
Franklin Resources
Kynam Capital Management
Baillie Gifford & Co
Samsara BioCapital
Millennium Management
Dimensional Fund Advisors
Goldman Sachs Group
Candriam Luxembourg S.C.A.
Vontobel Holding
PanAgora Asset Management
Pentwater Capital Management
Aquilo Capital Management
Jacobs Levy Equity Management

View all funds holding Sutro Biopharma